Neurotrope Inc

At the forefront of developing a new approach to combating #Alzheimer's disease and other neurodegenerative diseases $NTRP

[Neurotrope Inc @Neurotrope1]

After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug https://t.co/IqW5JSshON

[Neurotrope Inc @Neurotrope1]

Dr. Dan Alkon enjoyed his conversation with @moealsumidaie @Clin_Trials on the future #treatment for #alzheimers. #NTRP has only drug in development for moderate to severe #Alzheimers https://t.co/xGRwQaOf2r

[Erika Edwards @erikaedwardsnbc]

Vaping-related lung disease cases surge to nearly 300 nationwide https://t.co/XomAJeh2R5 via @nbcnews

[Alzheimer's Association, Florida Gulf Coast @AlzFLGulf]

Preparation is crucial. Emergency situations, like #HurricaneDorian, can significantly impact everyone’s safety, but they can be especially upsetting and confusing for individuals living with #Alzheimers and other dementias. For more info, visit https://t.co/etWhMkUaPo. #ENDALZ

[Neurotrope Inc @Neurotrope1]

#NTRP notes an article highlighting the synaptic deficiency hypothesis was published online in @TrendsinPharma
Dr. Dan Alkon "Bryostatin uses #novel mechanism action to generate new, mature synaptic connections & prevent #neuronal death in #AD.
https://t.co/LCF1ixvs2h

[Jim Greenwood @JimGreenwood]

I’m in @TheHill today with an open invitation for the 2020 presidential hopefuls: join me on a bus trip of hope. Let’s meet the scientists and researchers who work every day to get cures and treatments to the patients who need them. https://t.co/BR0L7HhX0j

[Neurotrope Inc @Neurotrope1]

"Our Improvement Data Is The Best Anyone Has"
Dr. Dan Alkon interviewed by @OthonasE for @Benzinga.
https://t.co/a7xAmxNkfH
#Alzheimer's #ENDALZ

[Neurotrope Inc @Neurotrope1]

Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results
https://t.co/gOyXLhgv7d

[Neurotrope Inc @Neurotrope1]

CEO Dr. Charles Ryan on @nasdaq #TradeTalks today speaking to @jillmalandrino "Our goal is to provide a therapeutic to individuals who have #Alzheimer's disease in which they have an improvement in cognitive function."
https://t.co/MAiEUQHZ2a

[TradeTalks @TradeTalks]

.@Nasdaq #TradeTalks: New Approach to Combatting Alzhemer’s Disease @Neurotrope1 @JillMalandrino $NTRP

[Neurotrope Inc @Neurotrope1]

Thank-you @JillMalandrino @nasdaq #TradeTalks for the conversation and platform to discuss @Neurotrope1 #Bryostatin, the only drug in development for moderate to severe #Alzheimer's disease.

[TradeTalks @TradeTalks]

.@Nasdaq #TradeTalks: New Approach to Combatting Alzhemer’s Disease @Neurotrope1 @JillMalandrino $NTRP

[Neurotrope Inc @Neurotrope1]

Thank you @CogRx CEO Ken Moch for your @PittsburghPG op-ed warning policymakers in Washington will consider proposals threatening to stifle progress in #Alzheimers research.
https://t.co/GJF4ZXzxvJ

[Ian Kremer @LEAD_Coalition]

A powerful reminder to those of us who do not have #Alzheimers disease or another form of #dementia to continue seeing and focusing on the whole person, to support #disabilities while respecting and embracing abilities.

[Neurotrope Inc @Neurotrope1]

Thank you @BillGates for your insight and investment. We @Neurotrope1 are fighting alongside you to treat moderate to severe #Alzheimer's disease.

[Bill Gates @BillGates]

It's hard to overstate how important finding a better diagnostic is for fighting #Alzheimers. That’s why I’m investing in new ideas for easier and more accurate diagnosis of the disease. https://t.co/WM9phNmyJo

[Ian Kremer @LEAD_Coalition]

Please re-Tweet to raise awareness that it is time to shed the #prejudice of low expectations and embrace the potential for living fully with #Alzheimers disease and other forms of #dementia.

[Neurotrope Inc @Neurotrope1]

Thank you @MTokarsky for your #Entrepreneurship #Kindness #Foresight #Intelligence and all good things required to build @investacure. Your efforts and #goodwill toward man are to be commended. #Alzheimers

[Neurotrope Inc @Neurotrope1]

CEO Dr. Charles Ryan receiving @investacure #CureCoinAward on behalf of @Neurotrope1 founder Dr. Daniel Alkon. Dr. Alkon was honored during #AAIC for his work in developing #Bryostatin, a natural compound showing promise in restoring synaptic networks in the brain.
#Alzheimers

[Neurotrope Inc @Neurotrope1]

Our @Neurotrope1 CEO Dr. Charles Ryan presenting at @alzassociation Conference in #LosAngeles this week. #NTRP has concluded data collection in Confirmatory Phase 2 trial. Results Q3. #AAIC2019 #AAIC19 #Alzheimers #AlzheimersDisease

[AP Health & Science @APHealthScience]

Two-thirds of Alzheimer’s cases in the U.S. are in women, and it's not just because they live longer. By @MMarchioneAP: https://t.co/NkvKDpNJCW

[Neurotrope Inc @Neurotrope1]

@Neurotrope1 Advisory Board Participates in KOL #Oppenheimer #Biotechnology Team Call. Friday July 19, 2019- 11 AM EST.
#Alzheimer's #Brain US/Canada [phone], passcode 2687039
International [phone], passcode 2687039

[Erika Edwards @erikaedwardsnbc]

Want to keep your brain sharp in old age? Go back to school https://t.co/nm4CrrK8ji via @nbcnews

[Neurotrope Inc @Neurotrope1]

Neurotrope Concludes Data Collection Confirmatory Phase 2 Trial of Moderately Severe to Severe #Alzheimer's Disease
https://t.co/N9uankkmeF